Filing metadata

Accession number
0001179110-21-005852
Form type
Form 4
Filer
Theravance Biopharma, Inc.
CIK
CIK 1583107
Filed
May 24, 2021
Reporting period
May 20, 2021
Description
Insider transaction

Explore SEC Filings Hub